KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 97 filers reported holding KRONOS BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $80,941,000 | 20.45% |
| Omega Fund Management, LLC | 3,818,283 | $111,761,000 | 10.57% |
| Wildcat Capital Management, LLC | 1,438,232 | $42,097,000 | 5.14% |
| COMMODORE CAPITAL LP | 298,839 | $8,747,000 | 3.48% |
| Alphabet Inc. | 1,438,232 | $42,097,000 | 1.70% |
| Octagon Capital Advisors LP | 146,173 | $4,278,000 | 1.61% |
| Perceptive Advisors | 2,780,097 | $79,671,000 | 1.01% |
| DSAM Partners (London) Ltd | 177,426 | $5,193,000 | 0.96% |
| Samsara BioCapital, LLC | 166,250 | $4,866,000 | 0.90% |
| Artal Group S.A. | 1,317,954 | $38,577,000 | 0.68% |